NICE's severity modifiers misalign with public preferences in England & Wales, prioritising health gains at lower disease ...

More collaborative initiatives are taking place among regulatory agencies, health technology assessment (HTA) bodies and ...

Ting (Tina) Wang is Associate Director, HTA Programme and Strategic Partnerships at the Centre for Innovation in Regulatory Science (CIRS). Tina leads CIRS’ work on HTA strategy and research as part ...

Stuart Carroll is a senior health economist and epidemiologist with over 18 years of experience, specialising in infectious diseases and vaccines, market access, health technology appraisal, public ...